anmelden
FTSE All-Share
5.634,42
PKT
-0,63
PKT
-0,01
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 12.04.24 | Diageo Sell | Deutsche Bank AG | |
| 12.04.24 | BAE Systems Buy | Deutsche Bank AG | |
| 11.04.24 | Vodafone Group Buy | UBS AG | |
| 10.04.24 | Vodafone Group Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 10.04.24 | HSBC Neutral | JP Morgan Chase & Co. | |
| 09.04.24 | BP Outperform | RBC Capital Markets | |
| 09.04.24 | Rio Tinto Buy | Jefferies & Company Inc. | |
| 09.04.24 | BP Overweight | Barclays Capital | |
| 09.04.24 | HSBC Neutral | JP Morgan Chase & Co. | |
| 09.04.24 | BP Underweight | JP Morgan Chase & Co. | |
| 09.04.24 | HSBC Neutral | UBS AG | |
| 09.04.24 | BP Buy | UBS AG | |
| 09.04.24 | Diageo Hold | Jefferies & Company Inc. | |
| 09.04.24 | BP Buy | Jefferies & Company Inc. | |
| 09.04.24 | BP Underweight | JP Morgan Chase & Co. | |
| 08.04.24 | GSK Equal Weight | Barclays Capital | |
| 08.04.24 | AstraZeneca Overweight | Barclays Capital | |
| 08.04.24 | Unilever Overweight | Barclays Capital | |
| 05.04.24 | Shell (ex Royal Dutch Shell) Overweight | Barclays Capital | |
| 05.04.24 | AstraZeneca Sell | UBS AG | |
| 05.04.24 | National Grid Buy | UBS AG | |
| 05.04.24 | Shell (ex Royal Dutch Shell) Neutral | UBS AG | |
| 05.04.24 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 05.04.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 05.04.24 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 05.04.24 | BP Underweight | JP Morgan Chase & Co. | |
| 05.04.24 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 04.04.24 | GSK Equal Weight | Barclays Capital | |
| 04.04.24 | Rio Tinto Overweight | Barclays Capital | |
| 04.04.24 | BP Buy | UBS AG | |
| 04.04.24 | Rio Tinto Buy | Deutsche Bank AG | |
| 04.04.24 | HSBC Sector Perform | RBC Capital Markets | |
| 04.04.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 04.04.24 | BP Outperform | RBC Capital Markets | |
| 04.04.24 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 03.04.24 | GSK Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 03.04.24 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 03.04.24 | BP Buy | Jefferies & Company Inc. | |
| 03.04.24 | Vodafone Group Underperform | Bernstein Research | |
| 02.04.24 | Unilever Overweight | Barclays Capital |